Fang Xia, a 24-year-old woman, has faced a lifelong struggle with obesity, a condition that has plagued her both physically and psychologically. But like millions of others around the world, her life was turned around after taking semaglutide, a glucagon-like peptide-1 (GLP-1) analog that mimics a hormone that triggers a sense of fullness and helps overweight people shed the pounds.
Caixin
China enlists 'miracle' drug in fight against ballooning obesity rate
Guidelines recommend medication be incorporated in weight-loss treatment
Danish company Novo Nordisk manufactures medication marketed under the Ozempic brand. Such drugs could have a major long-term impact in China and other countries where obesity is a major problem. © Reuters
Read Next
Latest on Caixin
